Search Results
Amarin CEO John Thero on company’s FDA approval for key heart drug
Amarin CEO on Future of Heart Drug Vascepa
Vascepa Is Safe and Should Be Approved by End of Year, Amarin CEO Says
Amarin CEO comments on its new medicine's mixed results in its drug trial
Amarin Corporation plc AMRN CEO John Thero on Q1 2020 Results
Is The Stock Amarin Completed?
FDA Approves Vascepa for Amarin Corp Plc(AMRN)
053 - Amarin Raises Guidance on Vascepa Label Expansion Approval. ASH Updates Impress!
Amarin Corp. $AMRN Fundamental Analysis
046 - FDA Announces Last Minute Advisory Committee For Amarin's Vascepa
joni me amarin
FDA Committee Says Vascepa Can Be Given To Larger Population Of Patients
